“Good Enough” Doesn’t Cut it in Value Assessment
IVI’s Jennifer Bright and Mark Linthicum write in STAT News that we’re squandering time and resources trying to find a neat answer to “what is value?” by focusing on the cost of drugs without tackling [...]
Steps Employers at the Crossroads of Healthcare Costs and Value Should Consider
IVI’s Jennifer Bright the president of the Institute for Integrated Benefits, Tom Parry, Ph.D., write in Fierce Healthcare that most employers have no idea how their benefit programs affect employee health outcomes. They outline a [...]
Crowdsourcing for Value in Healthcare
Value-based healthcare is predicated on collaboration. Sharing of data, methods, pathways and perspectives among different stakeholders is paramount if the transition to value-based care is to be fully realized. Instead of relying solely on legacy [...]
Watch Mark Linthicum’s “101 Course” on IVI’s New Non-Small Cell Lung Cancer Value Model
IVI's Director of Scientific Communications, Mark Linthicum, sits down with the Journal of Clinical Pathways for a webinar discussion about IVI's open-source model for assessing value in non-small cell lung cancer therapies. If you want to [...]
IVI to Hold Two Public Webinars on New Open-Source Model for Non-Small Cell Lung Cancer
IVI will host two upcoming webinars focused on its new disease-specific, open-source value model to assess EGFR+ non-small cell lung cancer (NSCLC) therapy sequences. These webinars are free and open to the public. We hope [...]
PRESS RELEASE: IVI Unveils New Value Assessment Model for Non-Small Cell Lung Cancer
IVI released our initial version of the new Open-Source Value Platform (OSVP) model for non-small cell lung cancer. Specifically, the model provides information on the relative value of sequential treatments for epidermal growth factor receptor [...]
How the Open Science Movement Creates Momentum for Value Assessment
In a Morning Consult commentary, IVI Executive Director, Jennifer Bright, discusses why transparency is a prerequisite to value-based reimbursement and how IVI's Open-Source Value Platform (OSVP) is an open laboratory for creating sophisticated systems to assess [...]
IVI’s Take on What’s In Store for Value Assessment in 2019
In an article published online by the American Journal of Managed Care, IVI's Executive Director, Jennifer Bright, and Director of Scientific Communications, Mark Linthicum, offer five predictions for where value assessment is headed in 2019. [...]
New IVI Research Shows Challenges with ICER Budget Impact Forecasting
IVI research into six pre-2016 ICER studies reveals an overestimation of “unmanaged” drug use and drug cost trends. The peer-reviewed research, published in Value in Health, illustrates the difficulty in predicting budget impact and the [...]
Value Frameworks Must Incorporate Real-World Evidence, Says Research Team Including IVI’s Darius Lakdawalla and Wayne Burton
In a new paper published by the American Journal of Managed Care, a team of researchers, including IVI's Darius Lakdawalla and Wayne Burton, conclude that key decision makers within our healthcare system need to recognize [...]
Journal of Clinical Pathways Podcast Focuses on Value
In an interview with the Journal of Clinical Pathways, IVI's Jennifer Bright and Mark Linthicum discuss how IVI is transforming value assessment. Read the transcript from the interview here.
Patient Perspectives Must Meaningfully Inform Value Measurement
In an article published on AJMC.com, IVI'sJennifer Bright discusses how IVI makes incorporating patients' perspectives a priority in developing open-source, transparent value models. Read the full article here.